Regulatory News
Tuesday, November 22, 2016
BRIEF-Allergan receives FDA clearance for a new surgical treatment for refractory glaucoma
* Allergan receives FDA clearance for the xen gel stent, a
new surgical treatment for refractory glaucoma
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment